Enable JavaScript to visit this website.

AtroPen® Auto-Injector

(atropine injection)

 
 

You Are Now Leaving the MeridianMeds.com Website

Links to other sites are provided as a convenience to the viewer.

Pfizer accepts no responsibility for the content of linked sites.

CANCEL
Product image Mobile: 

When there are organophosphorous nerve agents as well as organophosphorous or carbamate insecticides present, so may be the risk of poisoning. Four different dose strengths of AtroPen are available for use depending on the recipient's age and weight.3

Product indication: 

Indication:

The AtroPen Auto-Injector is indicated for the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as organophosphorous or carbamate insecticides.

The AtroPen Auto-Injector should be used by persons who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication. The AtroPen is intended as an initial treatment of the muscarinic symptoms of insecticide or nerve agent poisonings (generally breathing difficulties due to increased secretions); definitive medical care should be sought immediately.

 

Product Especification: 
To order or request a quote, call 1-800-638-8093
Key Product Specifications4:
NSN6505-00-926-9083 (2-mg military bulk pack)
NDC11704-101-01 (2-mg military bulk pack)11704-106-01 (2 mg)11704-105-01 (1 mg)11704-104-01 (0.5 mg)11704-107-01 (0.25 mg)
DeliversAtroPen® Auto-Injector is available in 4 dose strengths: 2 mg, 1 mg, and 0.5 mg atropine in 0.7 mL; and 0.25 mg atropine in 0.3 mL
Length of Unit100 mm (2 mg, 1 mg, 0.5 mg)144 mm (0.25 mg)
Diameter of Unit14 mm (2 mg, 1 mg, 0.5 mg)13 mm (0.25 mg)
Needle Gauge22
Needle Length21 mm (2 mg, 1 mg, 0.5 mg)13 mm (0.25 mg)
Administration TypeIntramuscular injection
Packaged1 auto-injector per box with instructions; package insert
24 auto-injectors per box (2-mg military bulk pack)
Packaging for Shipping(standard pack 2 mg, 1 mg, 0.5 mg)
12 units per shipper box (167 mm x 152 mm x 200 mm), weighing 0.6 kg
(standard pack for 0.25 mg)
12 units per shipper box (208 mm x 175 mm x 102 mm), weighing 0.7 kg
(bulk pack 1 mg, 0.5 mg)
144 units per shipper box
(483 mm x 356 mm x 254 mm), weighing 7.3 kg
(2 mg military bulk pack)
24 units per box
(133 mm x 124 mm x 73 mm), weighing 0.6 kg
24 interior boxes (576 units) per shipper box
(381 mm x 302 mm x 292 mm), weighing 13.4 kg
StorageStore at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F) [See USP Controlled
Room Temperature]. Keep from freezing.
Prescription RequiredYes

 

For medical: 

Adverse Event or Product Quality Complaints

If you wish to report an adverse event or product quality complaint, please call: 1-800-438-1985.

Medical Information

If you have a medical question concerning Meridian products, please call:
1-800-438-1985. US HCPs can visit www.pfizermedinfo.com.

Product image Desktop: 
Product trademark: 
View full Prescribing Information for AtroPen® Auto-Injector (atropine sulfate injection) ORDER OR REQUEST A QUOTE
AtroPen® is a registered trademark of Meridian Medical Technologies, Inc., a Pfizer company.

 

Important Safety Information and Indication
IMPORTANT SAFETY INFORMATION AND INDICATION

AtroPen® Auto-Injector (atropine injection)

In the face of life-threatening poisoning by organophosphorous nerve agents and insecticides, there are no absolute contraindications for the use of atropine.

Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments, including masks designed specifically for this use. Individuals should not rely solely upon antidotes such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Immediate evacuation from the contaminated environment is essential. Decontamination of the poisoned individual should occur as soon as possible.

AtroPen should be administered with extreme caution to individuals with the following disorders when the symptoms of nerve agent poisoning are less severe: individuals who are hypersensitive to any component of the product, disorders of heart rhythm such as atrial flutter, severe narrow-angle glaucoma, pyloric stenosis, prostatic hypertrophy, significant renal insufficiency, or a recent myocardial infarction.

No more than three doses should be administered unless under the supervision of trained medical personnel. Children and the elderly may be more susceptible to the pharmacologic effects of atropine.

Severe difficulty in breathing requires artificial respiration in addition to the use of atropine since atropine is not dependable in reversing the weakness or paralysis of the respiratory muscles.

Atropine should be administered to a pregnant woman only if clearly needed.

Mild to moderate pain may be experienced at the site of injection. The major and most common side effects of atropine can be attributed to its antimuscarinic action and include dryness of the mouth, blurred vision, photophobia, confusion, headache, dizziness, and anhidrosis, among others.

Indication:

The AtroPen Auto-Injector is indicated for the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as organophosphorous or carbamate insecticides.

The AtroPen Auto-Injector should be used by persons who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication. The AtroPen is intended as an initial treatment of the muscarinic symptoms of insecticide or nerve agent poisonings (generally breathing difficulties due to increased secretions); definitive medical care should be sought immediately.